Semaglutyd (agonista receptora glukagonopodobnego peptydu , GLP-1), okazał się bezpieczny i skuteczny w leczeniu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback